Tumor group (N) | ITSS | τba | P | ||
---|---|---|---|---|---|
0 | 1 | 2 | |||
All tumor (64) | 0.496 | < 0.001* | |||
Low grade | 14 (48.3%) | 11 (37.9%) | 4 (13.8%) | ||
High grade | 4 (11.4%) | 9 (25.7%) | 22 (62.9%) | ||
Supratentorial (41) | 0.451 | 0.002* | |||
Low grade | 9 (45%) | 8 (40%) | 3 (15%) | ||
High grade | 3 (14.3%) | 5 (23.8%) | 13 (61.9%) | ||
Infratentorial (23) | 0.571 | 0.005* | |||
Low grade | 5 (55.6%) | 3 (33.3%) | 1 (11.1%) | ||
High grade | 1 (7.1%) | 4 (28.6%) | 9 (64.3%) | ||
Off-midline (42) | 0.496 | 0.001* | |||
Low grade | 8 (42.1%) | 8 (42.1%) | 3 (15.8%) | ||
High grade | 2 (8.7%) | 6 (26.1%) | 15 (65.2%) | ||
Astrocytoma (33) | 0.425 | 0.011* | |||
Low grade | 9 (47.4%) | 7 (36.8%) | 3 (15.8%) | ||
High grade | 2 (14.3%) | 4 (28.6%) | 8 (57.1%) | ||
Neuronal and mixed glioneuronal tumor (11) | 0.462 | 0.125 | |||
Low grade | 5 (50%) | 4 (40%) | 1 (10%) | ||
High grade | 0 | 0 | 1 (100%) | ||
Embryonal (12) | – | – | |||
Low grade | – | – | – | ||
High grade | 0 | 4 (33.3%) | 8 (66.7%) | ||
Ependymoma (6) | – | – | |||
Low grade | – | – | – | ||
High grade | 1 (167%) | 1 (16.7%) | 4 (66.7%) | ||
Other (2) | – | – | |||
Low grade | – | – | – | ||
High grade | 1 (50%) | 0 | 1 (50%) |